Intel Corporation's stock declined by more than 6% in February 2026, marking its worst monthly performance in over a year. The drop followed renewed concerns over chip manufacturing timelines and intensified competition in the semiconductor market.
- Intel stock dropped over 6% in February 2026, the largest monthly decline in over 12 months
- 18A manufacturing node delays pushed key milestones beyond 2026
- Gross margin declined to 56.4% in Q4 2025, down from 59.1% in Q3
- R&D expenses rose 9% YoY to $15.3 billion in 2025
- SOXX index fell 3.2% and XLK slipped 2.1% during the same period
- Capital expenditure for 2026 remains at $25 billion despite margin pressures
Intel's stock fell more than 6% during February 2026, erasing over $25 billion in market value, according to trading data. The decline coincided with updated guidance from Intel management, which acknowledged further delays in the ramp-up of its 18A process node, the company's next-generation manufacturing technology. The delay pushed back critical milestones beyond the 2026 timeframe, raising questions about Intel's ability to regain technological parity with rivals like TSMC and Samsung. The company also reported a sequential drop in revenue for its PC and data center segments, contributing to investor unease. The broader semiconductor sector was affected, with the SOXX index dropping 3.2% over the same period. The XLK ETF, which tracks the technology sector, declined 2.1%, reflecting broader concerns about hardware capital expenditure trends. Analysts noted that Intel’s struggles are increasingly being viewed as a proxy for wider challenges in semiconductor capital intensity and shifting demand dynamics, particularly in enterprise and cloud infrastructure. Key metrics highlight the pressure: Intel's gross margin fell to 56.4% in Q4 2025, down from 59.1% the prior quarter, while its R&D expenses rose 9% year-over-year to $15.3 billion. These figures underscore the financial strain of maintaining a dual focus on legacy production and next-gen process development. The company’s capital expenditure for 2026 remains at $25 billion, a level analysts say may not be sufficient to close the technology gap without operational breakthroughs. Investors are now closely monitoring upcoming earnings and the company’s roadmap announcements, particularly around the 18A node and the long-anticipated Arrow Lake processors. The semiconductor space remains volatile, with tech investors adjusting expectations for hardware growth amid a global slowdown in consumer electronics demand.